
An innovative spray helped men with premature ejaculation last six times longer, a new study says.
The study tested the effectiveness of the PSD502 spray, developed to prolong
sexual intercourse for men diagnosed with premature ejaculation. The
PSD502 spray contains two drugs lidocaine and prilocaine and is applied locally five minutes before the intercourse.

Scientists say that premature ejaculation may be an inherited disorder linked to genes.
A study conducted by Finnish researchers Pekka Santtila, Kenneth Sandnabba and Patrick Jern revealed that many men faced the problem of
premature ejaculation and
erectile dysfunction at their fist sexual experience.

A novel drug to treat
premature ejaculation was approved and is now available in New Zealand pharmacies.
PRILIGY®, a drug containing
dapoxetine hydrochloride is recommended for men with premature ejaculation aged 18 to 64.

Almost every man faces the problem of
premature ejaculation at least once in his lifetime. Premature ejaculation is an inability to control ejaculation, which usually occurs shortly after sexual intercourse begins or prior to it.